Bildkälla: Stockfoto

Medivir: IND Approval for Phase IIb - Redeye

Today, Medivir announced its application to start a phase II study in liver cancer was approved by the FDA, which we discuss.

Today, Medivir announced its application to start a phase II study in liver cancer was approved by the FDA, which we discuss.
Börsvärldens nyhetsbrev
ANNONSER